SCHEMBL4475617

SCHEMBL4475617

NC(=O)C1CC(O)C(C(=O)N2CCN(c3ccccc3)CC2)C(O)C1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TFPI2 P48307 1/20 0.53
▸ SIGMAR1 Q99720 1/20 0.52
▸ KMT2A Q03164 3/20 0.49
▸ MEN1 O00255 2/20 0.49
▸ MAPT P10636 4/20 0.47
▸ TP53 P04637 2/20 0.47
▸ LMNA P02545 4/20 0.47
▸ TSHR P16473 4/20 0.47
▸ NPSR1 Q6W5P4 2/20 0.47
▸ ALDH1A1 P00352 3/20 0.47
▸ USP2 O75604 1/20 0.47
▸ POLB P06746 1/20 0.46
▸ HTT P42858 1/20 0.46
▸ RAB9A P51151 1/20 0.46
▸ CYP2C9 P11712 2/20 0.45
▸ CYP2C19 P33261 2/20 0.45
▸ ADAM10 O14672 1/20 0.45
▸ ERBB2 P04626 1/20 0.45
▸ MMP2 P08253 1/20 0.45
▸ AKR1C3 P42330 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3529467 0.76 NOTUM (0.64) KMT2AMEN1MAPTTSHRNPSR1
SCHEMBL16356982 0.75 TDP1 (0.73) TFPI2SIGMAR1KMT2AMEN1MAPT
Benzene SCHEMBL28217786 0.75 NOTUM (0.62) KMT2AMEN1MAPTTSHRNPSR1
Hydrochloric Acid SCHEMBL28060567 0.75 NOTUM (0.62) KMT2AMEN1MAPTTSHRNPSR1
SCHEMBL3867043 0.72 HTR1A (0.67) KMT2AMEN1MAPTLMNATSHR
SCHEMBL22494771 0.72 TDP1 (0.56) TFPI2SIGMAR1KMT2AMEN1MAPT
SCHEMBL6472537 0.71 TSHR (0.65) KMT2AMEN1MAPTTSHRALDH1A1
SCHEMBL2183374 0.70 NOTUM (0.75) KMT2AMEN1NPSR1ALDH1A1POLB
SCHEMBL16695124 0.70 NOTUM (0.75) KMT2AMEN1NPSR1ALDH1A1POLB
SCHEMBL3180448 0.70 ALDH1A1 (0.61) KMT2AMEN1MAPTLMNATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7491724-B2 Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases INCYTE CORPORATION (US) 2009-02-17 — — US disclosed
US-20050113344-A1 Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases INCYTE CORPORATION 2005-05-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050113344-A1 Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases MMP25, MMP2, MMP14 TFPI2 257/4885SIGMAR1 3105/4885KMT2A 1880/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback